Loading...
Search for: rapamycin
0.005 seconds

    Rapamycin Loaded Chitosan Nanopartilces to Cure Coronary Artery Blockage: Synthetize And Characterization

    , M.Sc. Thesis Sharif University of Technology Manafi Rad, Arash (Author) ; Simchi, Abdolreza (Supervisor) ; Shokrgozar, Mohammad Ali (Supervisor)
    Abstract
    Coronary artery diseaseaffects millions of persons and isone of the leading causes of morbidity and mortality worldwide. Invasive techniques such as coronary artery bypassgrafting are used to alleviate the lesion of arterial occlusion.Unfortunately, restenosis or occlusion of the graftedconduit occurs over a time frame of months to years with a gradual reduction in patency, especially in vein grafts. Theevents leading to intimal hyperplasia (IH) formation involve numerous cellular and molecular components. Variouscellular elements of the vessel wall are involved as are leucocyte–endothelial interactions that trigger the coagulationcascade leading to localized thrombus formation. Subsequent... 

    Nanotechnology in diagnosis and treatment of coronary artery disease

    , Article Nanomedicine ; Volume 11, Issue 5 , 2016 , Pages 513-530 ; 17435889 (ISSN) Karimi, M ; Zare, H ; Bakhshian Nik, A ; Yazdani, N ; Hamrang, M ; Mohamed, E ; Sahandi Zangabad, P ; Moosavi Basri, S. M ; Bakhtiari, L ; Hamblin, M. R ; Sharif University of Technology
    Future Medicine Ltd 
    Abstract
    Nanotechnology could provide a new complementary approach to treat coronary artery disease (CAD) which is now one of the biggest killers in the Western world. The course of events, which leads to atherosclerosis and CAD, involves many biological factors and cellular disease processes which may be mitigated by therapeutic methods enhanced by nanotechnology. Nanoparticles can provide a variety of delivery systems for cargoes such as drugs and genes that can address many problems within the arteries. In order to improve the performance of current stents, nanotechnology provides different nanomaterial coatings, in addition to controlled-release nanocarriers, to prevent in-stent restenosis.... 

    Oncolytic paramyxoviruses-induced autophagy; A prudent weapon for cancer therapy

    , Article Journal of Biomedical Science ; Volume 26, Issue 1 , 2019 ; 10217770 (ISSN) Keshavarz, M ; Solaymani Mohammadi, F ; Miri, S. M ; Ghaemi, A ; Sharif University of Technology
    BioMed Central Ltd  2019
    Abstract
    Oncolytic virotherapy has currently emerged as a promising approach upon which scientists have been able to induce tumor-specific cell death in a broad spectrum of malignancies. Paramyxoviruses represent intrinsic oncolytic capability, which makes them excellent candidates to be widely used in oncolytic virotherapy. The mechanisms through which these viruses destroy the cancerous cells involve triggering the autophagic machinery and apoptosis in target cells. Interestingly, oncolytic paramyxoviruses have been found to induce autophagy and lead to tumor cells death rather than their survival. Indeed, the induction of autophagy has been revealed to enhance the immunogenicity of tumor cells via...